Organogenesis Holdings Inc (FRA:2PQ)
€ 2.9 -0.12 (-3.97%) Market Cap: 383.32 Mil Enterprise Value: 396.10 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 74/100

Organogenesis Holdings Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2021 / 02:40PM GMT
Release Date Price: €9.6 (+4.92%)
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

Right. Well, listen, I apologize for the late start. So we're 5 minutes in, but hopefully we'll be able to get through some of the things we'd like to talk about. Gary and Dave, thanks so much for joining us. My name is Matt Miksic. I cover Medical Devices at Crédit Suisse. We're very pleased to have the team from Organogenesis with us today, Gary Gillheeney and Dave Francisco, thanks again.

Gary S. Gillheeney
Organogenesis Holdings Inc. - President, CEO & Director

Thank you, Matt. We're happy to be here.

Questions & Answers

Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

So we've been starting many of the sessions this week with questions around the environment and staffing and COVID surge and so on. But I thought given that the amount of attention that has been given to Affinity over the past 4 to 6 weeks and some of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot